Evidence map›Paper›PMID 33178017›Full record

ArticleFrontiers in pharmacology2020

Glabridin Attenuates the Retinal Degeneration Induced by Sodium Iodate

Kaung Htet Aung, Hua Liu, Zongwen Ke, Shuang Jiang, Jianhua Huang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Subinhibitory concentrations of glabridin fromFrontiers in microbiology · 2024
    Article
  6. Article
  7. Review on the Diverse Biological Effects of Glabridin.Drug design, development and therapy · 2023
    Review
  8. Article
  9. Medication Trends for Age-Related Macular Degeneration.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kaung Htet AungDepartment of Ophthalmology, Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Hua LiuDepartment of Ophthalmology, Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Zongwen KeGraduate School of Jinzhou Medical University, Jinzhou, China.
Shuang JiangDepartment of Ophthalmology, Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Jianhua HuangKey Laboratory of Surgery of Liaoning Province, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Jinzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAge-related macular degeneration (AMD) is one of the major causes of blindness in the elderly over the age of 60. AMD is divided into dry AMD and wet AMD. Although there are certain treatment methods for wet age-related macular degeneration (AMD), there are no effective treatments for dry AMD yet, and finding new drugs or treatment methods for dry AMD has become a priority. For this purpose, this study explored Glabridin (Glab), an isoflavane found in the root extract of licorice, which has never been investigated in relation to eye diseases. PURPOSE: To investigate the effect of Glab on the sodium iodate (NaIO

methods

results

conclusionGlabridin has a protective effect against retinal degeneration. It is suggested that Glab be further investigated for the treatment of retinal degeneration diseases.

Indexed as

age-related macular degenerationapoptosisglabridinoxidative stressretinal pigment epithelial (RPE) cellssodium iodate

Identifiers

PMID33178017
PMCPMC7593553
OpenAlexW3093345033

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.